Treatment of functional limitations at the knee in ambulatory children with cerebral palsy

被引:27
作者
Chambers, HG [1 ]
机构
[1] Childrens Hosp & Hlth Ctr, San Diego, CA 92123 USA
关键词
botulinum toxin; cerebral palsy; gait; knee disorders;
D O I
10.1046/j.1468-1331.2001.00039.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The gait of ambulatory children with cerebral palsy frequently involves abnormal knee motion. Spasticity, muscle contracture formation, impairments of motor control, weakness. balance deficits. and extrapyramidal motions can all contribute to the functional limitations imposed at the knee. Careful clinical evaluation of the child and their gait must be performed in order to determine the best individual course of treatment. Often, three-dimensional motion analysis with assessment of muscle activity and force is necessary to completely assess the complexities of gait. Several typical gait patterns have been described involving the knee, including 'jump knee'. crouch'. 'true equinus', 'apparent equinus', 'recurvatum' and 'stiff knee' gait. Each of these gait patterns is defined here and discussed using case examples. These typical gait patterns are usually accompanied by involvement at the hip and ankle and may be combined with transverse plane rotational abnormalities. Treatment options such as rehabilitation (physiotherapy, casting, strengthening, and/or orthoses). spasticity management (intramuscular injections of phenol. alcohol. and botulinum toxin type A) and orthopaedic approaches are discussed for each entity.
引用
收藏
页码:59 / 74
页数:16
相关论文
共 69 条
[1]  
Abel MF, 1999, J PEDIATR ORTHOPED, V19, P366
[2]   Intrathecal baclofen in cerebral palsy movement disorders [J].
Albright, AL .
JOURNAL OF CHILD NEUROLOGY, 1996, 11 :S29-S35
[3]   Continuous intrathecal baclofen infusion for symptomatic generalized dystonia [J].
Albright, AL ;
Barry, MJ ;
Fasick, P ;
Barron, W ;
Shultz, B .
NEUROSURGERY, 1996, 38 (05) :934-938
[4]   Baclofen in the treatment of cerebral palsy [J].
Albright, AL .
JOURNAL OF CHILD NEUROLOGY, 1996, 11 (02) :77-83
[5]  
ANDERSON JP, 1988, DEV MED CHILD NEUROL, V30, P502
[6]  
Atar Dan, 1993, Bulletin Hospital for Joint Diseases, V53, P34
[7]   Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy [J].
Boyd, RN ;
Graham, HK .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 :S23-S35
[8]  
BUCKON C, 1999, DEV MED CHILD NEUROL, V41, P21
[9]  
Camacho FJ, 1996, ORTHOPEDICS, V19, P319
[10]   Prediction of outcome after rectus femoris surgery in cerebral palsy: The role of cocontraction of the rectus femoris and vastus lateralis [J].
Chambers, H ;
Lauer, A ;
Kaufman, K ;
Cardelia, JM ;
Sutherland, D .
JOURNAL OF PEDIATRIC ORTHOPAEDICS, 1998, 18 (06) :703-711